InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+177.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Thomson Peter G., Vice-Président Finance et Comptabilité. Director active across 1 company, notably Fulcrum Therapeutics, Inc.. Aggregated, 2 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €35k. History available since 28 June 2021. The latest transaction was filed on 28 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
2,300 shares@ US$9.000.0039% mcap50.0% of flowCommon StockSEC:0000899243-21-026555:0
Ideal exit: 25 Mar 2022 (T+270)
2,300 shares@ US$9.0050.0% of flowCommon StockSEC:0000899243-21-026555
Ideal exit: 25 Mar 2022 (T+270)
2 of 2 declarations
About Thomson Peter G.
Thomson Peter G. is the Vice President of Finance and Accounting at Fulcrum Therapeutics, Inc. In this role, he is responsible for the financial management and accounting of the company. He oversees financial reporting, budgeting, and regulatory compliance. His expertise in finance is essential to support the company's growth strategy and ensure effective management of financial resources.
